Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon beta-1a versus standard therapy for MS-associated and primary intermediate uveitis
2004-004403-37Phase 3Terminated
- Sponsor
- Heidelberg University Hospital
- Start
- Oct 2005
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of interferon beta-1a in Hyalitis and multiple sclerosis (MS) (2 arms), sponsored by Heidelberg University Hospital. Primary endpoint: Change in visual acuity. Started Oct 2005; status: terminated.
02
Drugs
interferon beta-1a
03
Conditions
Hyalitismultiple sclerosis (MS)
Beyond the preview
Go deeper on 2004-004403-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004403-37.